J&J Vision Care accepting UV research proposals

Article

Are you interested in conducting research for J&J Vision Care? The company is actively soliciting proposals for research on UV and the eye.

Jacksonville, FL-Johnson & Johnson Vision Care, Inc. (JJVCI) is now accepting research proposals related to ultraviolet (UV) radiation and the human eye. Specific areas of interest include the following topics:

• Eye health, including photoageing (cataractogenesis, presbyopia, corneal, retinal, conjunctival/limbal changes)

• Epidemiology of UV-induced ocular disease, including geographic, ethnic, and occupational study. Proposals may include the study of indoor and outdoor UV radiation. Increased risk associated with UV exposure in youth.

• Assessing the protective effect of UV-blocking contact lenses on human ocular tissues including methodology, measurement techniques, and clinical endpoints. Comparative protective effects of contact lenses and spectacles/sunglasses.

Research proposals must be submitted through the JJVCI Investigator Initiated Study (IIS) application process by contacting the clinical research administrator via e-mail at RA-VISUS-IISRequests@its.jnj.com or by calling at +1-904-443-1525. All research proposals must be submitted in English.

For additional information on JJVCI’s IIS process and policy, visit  http://www.acuvueprofessional.com/investigator-initiated-studies

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.